12:00 AM
 | 
Apr 26, 2010
 |  BC Week In Review  |  Company News  |  Deals

Azur Pharma, Douglas Pharmaceuticals deal

Azur received U.S. rights from Douglas' Douglas Pharmaceuticals America Ltd. unit to commercialize an oral suspension formulation of clozapine to...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >